Ats Genetech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.79 M
- Revenue Growth 18.54%
- Profit Growth 43.55%
- Ebitda 15.49%
- Net Worth -7.58%
- Total Assets -6.62%
About Ats Genetech
Ats Genetech Private Limited (AGPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 July 1998 and has a history of 26 years and seven months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹9.79 M.
Veera Udumudi and Anuradha Udumudi serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100TG1998PTC029694
-
Company No.
029694
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Jul 1998
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Ats Genetech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veera Udumudi
|
Director | 01-Jul-1998 | Current |
|
Anuradha Udumudi
|
Director | 01-Jul-1998 | Current |
Financial Performance of Ats Genetech.
Ats Genetech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.54% increase. The company also saw a substantial improvement in profitability, with a 43.55% increase in profit. The company's net worth dipped by a decrease of 7.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ats Genetech?
In 2023, Ats Genetech had a promoter holding of 74.55% and a public holding of 25.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Fertinome Biosciences Private LimitedVeera Udumudi and Anuradha Udumudi are mutual person
Charges (Loans)
₹9.79 M
₹0
Charges Breakdown by Lending Institutions
- Icici Bank Ltd : 0.49 Cr
- Hdfc Bank Limited : 0.48 Cr
- Andhra Bank : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2016 | Hdfc Bank Limited | ₹4.75 M | Open |
| 11 Mar 2005 | Icici Bank Ltd | ₹1.20 M | Open |
| 25 Aug 2004 | Icici Bank Ltd | ₹3.70 M | Open |
| 30 Oct 1998 | Andhra Bank | ₹0.14 M | Open |
How Many Employees Work at Ats Genetech?
Ats Genetech has a workforce of 19 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ats Genetech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ats Genetech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
